There are 2789 resources available
1610P - Delivery of ONCOlogic care at HOME: Ready for “ONCOHOME”
Presenter: Margherita Ratti
Session: ePoster Display
1709P - Prediction of febrile neutropenia (FN), hospitalization (Hosp) rates, and infection (Inf) rates in chemotherapy-induced neutropenia (CIN) patients (pts) treated with the plinabulin and pegfilgrastim combination (Plin+Peg) using a meta-analysis (MA)-based tool
Presenter: Stephan Ogenstad
Session: ePoster Display
1710P - Impact of adding plinabulin to pegfilgrastim for the prevention of chemotherapy induced neutropenia (CIN) on patient quality of life (QoL)
Presenter: Douglas Blayney
Session: ePoster Display
1711P - Real-world study of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal tumors
Presenter: Nong Xu
Session: ePoster Display
1712P - Safety and efficacy of influenza and pneumococcal vaccines in cancer patients on active therapy: A prospective study
Presenter: Nicla Maria La Verde
Session: ePoster Display
1615P - Impact of the COVID-19 pandemic on diagnosing and treatment referrals of lung cancer patients: A single-centre experience
Presenter: Urska Janzic
Session: ePoster Display
1714P - Edmonton symptom assessment system (ESAS)-total care (TC): Development and psychometric validation in Italian language of ESAS-TC in patients undergoing cancer treatment and follow-up
Presenter: Carla Ripamonti
Session: ePoster Display
1617P - Sustained cancer clinical trial activity during the COVID-19 pandemic
Presenter: Arnaud Bayle
Session: ePoster Display
1716P - Do proton pump inhibitors affect the survival outcomes and safety in colorectal cancer patients treated with regorafenib? A single center and real-life experience
Presenter: Emre Yekeduz
Session: ePoster Display
1619P - Transition to a virtual cancer multidisciplinary team meeting during the COVID-19 pandemic: Experience from a regional Irish Cancer Centre
Presenter: Caitriona Goggin
Session: ePoster Display